Cargando…

Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures

Contrast-induced nephropathy (CIN) is a frequent and severe complication in subjects receiving iodinated contrast media for diagnostic or therapeutic purposes. Several preventive strategies were evaluated in the past. Recent clinical studies and meta-analyses delivered some new aspects on preventive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patschan, D., Buschmann, I., Ritter, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954945/ https://www.ncbi.nlm.nih.gov/pubmed/29854458 http://dx.doi.org/10.1155/2018/5727309

Ejemplares similares

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention
por: Geenen, Remy W. F., et al.
Publicado: (2013)

Contrast-induced Nephropathy
por: Mohammed, Nazar M. A., et al.
Publicado: (2013)

Crystalloid fluid therapy
por: Reddy, Sumeet, et al.
Publicado: (2016)

Contrast induced nephropathy in urology
por: Thomson, Viji Samuel, et al.
Publicado: (2009)

Quality of care in patients undergoing coronary angiography with a known risk of contrast-associated acute kidney injury: a retrospective observational study
por: Hild, Julian, et al.
Publicado: (2022)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

Contrast-induced nephropathy in interventional cardiology
por: Sudarsky, Doron, et al.
Publicado: (2011)

Contrast induced nephropathy; recent findings
por: Mardani, Saeed, et al.
Publicado: (2013)

Balanced crystalloids for septic shock resuscitation
por: Corrêa, Thiago Domingos, et al.
Publicado: (2016)

Is Contrast Medium Osmolality a Causal Factor for Contrast-Induced Nephropathy?
por: Bucher, Andreas M., et al.
Publicado: (2014)

Health Care Quality in CKD Subjects: A Cross-Sectional In-Hospital Evaluation
por: Rzayeva, L., et al.
Publicado: (2022)

Uric acid and contrast-induced nephropathy: an updated review and meta-regression analysis
por: Pelliccia, Francesco, et al.
Publicado: (2018)

Bench-to-bedside review: Preventive measures for contrast-induced nephropathy in critically ill patients
por: van den Berk, Guido, et al.
Publicado: (2005)

AKI Epidemiology and Outcomes: A Retrospective Cohort Study from the Prenephrology Era
por: Asmus, K., et al.
Publicado: (2021)

Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?
por: Erfurt, Stefan, et al.
Publicado: (2021)

Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?
por: Patschan, Daniel, et al.
Publicado: (2022)

Metabolomics in Acute Kidney Injury: The Clinical Perspective
por: Patschan, Daniel, et al.
Publicado: (2023)

Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
por: Xu, Zhongchi, et al.
Publicado: (2022)

Crystalloids in salivary gland lesions
por: Issac, Reeba Mary, et al.
Publicado: (2014)

Crystalloid and Colloid Compositions and Their Impact
por: Rudloff, Elke, et al.
Publicado: (2021)

Balanced Crystalloids in Sepsis: Are We There Yet?
por: Hammond, Drayton A., et al.
Publicado: (2020)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
por: Panova, Ina G., et al.
Publicado: (2023)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Contrast-induced nephropathy – a review of current literature and guidelines
por: Maliborski, Artur, et al.
Publicado: (2011)

Kidney Replacement Therapy in Cardiorenal Syndromes
por: Patschan, Daniel, et al.
Publicado: (2022)

Dose and type of crystalloid fluid therapy in adult hospitalized patients
por: Smorenberg, Annemieke, et al.
Publicado: (2013)

The role of inflammation in contrast-induced nephropathy
por: Kwasa, E A, et al.
Publicado: (2014)

Biogenesis of the Protein Storage Vacuole Crystalloid
por: Jiang, Liwen, et al.
Publicado: (2000)

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
por: Jo, Sang-Ho
Publicado: (2011)

Contrast safety in the cancer patient: preventing contrast-induced nephropathy
por: Heiken, Jay P.
Publicado: (2008)

HUMAN HEPATIC MICROBODIES WITH CRYSTALLOID CORES
por: Biempica, Luis
Publicado: (1966)

A CRYSTALLOID INCLUSION IN THE RABBIT BLASTOCYST
por: Hadek, Robert, et al.
Publicado: (1960)

Erratum: Crystalloid and Colloid Compositions and Their Impact
por: Frontiers Production Office,
Publicado: (2022)

Metabolomics in Acute Kidney Injury: The Experimental Perspective
por: Patschan, Daniel, et al.
Publicado: (2023)

Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy?
por: Heyman, Samuel N., et al.
Publicado: (2013)

Balanced crystalloids versus isotonic saline in critically ill patients: systematic review and meta-analysis
por: Zayed, Yazan Z. M., et al.
Publicado: (2018)

Association of cytokine patterns and clinical/laboratory parameters, medication and periodontal burden in patients with rheumatoid arthritis (RA)
por: Patschan, S., et al.
Publicado: (2020)

The efficacy of remote ischemic conditioning in preventing contrast‐induced nephropathy among patients undergoing coronary angiography or intervention: An updated systematic review and meta‐analysis
por: Zhan, Biming, et al.
Publicado: (2019)

Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches
por: Kusirisin, Prit, et al.
Publicado: (2020)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aqn4hutto2tfmloj6n5u942npf